Factors Contributing to Molar Pregnancy Through a Study in Jiblah University Hospital, IBB: Study from 2017 to 2022
DOI:
https://doi.org/10.59992/IJSR.2024.v3n5p15Keywords:
Hydatidiform Mole, Molar Pregnancy, Prevalence, Clinical Presentation, Yemen, Jiblah University HospitalAbstract
Background: The reported prevalence rates of hydatidiform mole (HM) vary greatly across geography and time, making worldwide comparisons challenging, especially in developing countries and resource-limited settings. To date, few studies have been reported in Yemen regarding the epidemiology, management, and outcome of patients with HM. The current study sought to investigate the prevalence of HM among women who visited a large tertiary center at Jiblah University Hospital in Yemen.
Method: A retrospective study was conducted between Jun 2017 and Sep 2022 at Jiblah University Hospital, Ibb, Yemen including all women with a diagnosis of HM. Complete medical histories for all HM patients were collected and analyzed.
Results: A total of 160 women diagnosed with HM at Jiblah University Hospital -Ibb study from 2017 to 2022 years were included in the study. The mean gestational age on admission was 25.2 years. Sixty-two patients (38.7%) have Hb less than normal range and 94 of patients (58.8 %) have Hb normal range 12- 15g/dl and 4 patients (2.5 %) have Hb more than normal range 15g/dl. However, the percentage blood types (A+, A-, B-, B+, O+, O- and AB+) were 40.6%, 0.6%, 5%, 0.6%, 41.9 %, 7.5% and 3.8%, respectively.
On the other hand, among the sample, 4 (2.5%) women were diagnosed histopathologically to have previous V.M and while 156 (97.5%) women were diagnosed histopathologically to have no previous V.M. A number of women who had previous abortion were recorded 46(28.7%) and while the women had not previous abortion was 114(41.4%). Among the women who had smoking and no smoking were recorded 2(1.3%) and 158(98.7%), respectively. Finally, unfortunately the researchers didn’t find following risk factors in the register of patients, such as (Ovulation induction, genes mutation, infertility and birth control pills), by researching the record of patients with HM or registered as having HM. However, our study found the relationship between age groups and the previous abortion about associate risk factors of molar pregnancy. There is statistically significant difference between previous abortion and age, with P-value =0.007.
Conclusion: The present study showed that incident hydatidiform mole were higher in 20-29 years of maternal age, so we found that the incidence of HM in younger age patients is the most common. Also, we found that the significant positive correlation was found between age with previous abortions. Therefore, it is recommended that women should undergo health care before pregnancy and further studies are required to provide solutions to reduce the cases of HM.
References
1. Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010 Dec;203(6):531-9. doi: 10.1016/j.ajog.2010.06.073. Epub 2010 Aug 21. PMID: 20728069.
2. Bracken MB. Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol. 1987 Dec;94(12):1123-35. doi: 10.1111/j.1471-0528.1987.tb02311.x. PMID: 3322372.
3. Eysbouts YK, Bulten J, Ottevanger PB, Thomas CM, Ten Kate-Booij MJ, van Herwaarden AE, Siebers AG, Sweep FC, Massuger LF. Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study. Gynecol Oncol. 2016 Jan;140(1):70-5. doi: 10.1016/j.ygyno.2015.11.014. Epub 2015 Nov 14. PMID: 26586414.
4. Ahmed, I. A. M. (2013). Gestational trophoblastic disease in Al-Thawra Hospital, Sana’a-Yemen. Yemeni journal for medical sciences, 7(1), 1-7.
5. Al Alaf, S.K., Ibrahim D. (2010). Prevalence and clinical observations of gestational trophoblastic diseases in maternity teaching hospital in Erbil city. WSEAS Transactions on. Biology and Biomedicine;7(3):190-199.
6. Javey H, Sajadi H. Hydatidiform mole in southern Iran: a statistical survey of 113 cases. Int J Gynaecol Obstet. 1978;15(5):390-5. doi: 10.1002/j.1879-3479.1977.tb00716.x. PMID: 28969.
7. Kitange B, Matovelo D, Konje E, Massinde A, Rambau P. Hydatidiform moles among patients with incomplete abortion in Mwanza City, North western Tanzania. Afr Health Sci. 2015 Dec;15(4):1081-6. doi: 10.4314/ahs.v15i4.5. PMID: 26958007; PMCID: PMC4765400.
8. Kim SJ, Lee C, Kwon SY, Na YJ, Oh YK, Kim CJ. Studying changes in the incidence, diagnosis and management of GTD: the South Korean model. J Reprod Med. 2004 Aug;49(8):643-54. PMID: 15457855.
9. Matsui H, Kihara M, Yamazawa K, Mitsuhashi A, Seki K, Sekiya S. Recent changes of the incidence of complete and partial mole in Chiba prefecture. Gynecol Obstet Invest. 2007;63(1):7-10. doi: 10.1159/000094388. Epub 2006 Jul 4. PMID: 16825782.
10. Joneborg U, Folkvaljon Y, Papadogiannakis N, Lambe M, Marions L. Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study. Acta Oncol. 2018 Aug; 57(8):1094-1099.
doi: 10.1080/0284186X.2018.1438653. Epub 2018 Feb 16. PMID: 29451409.
11. Steigrad SJ. Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003 Dec;17(6):837-47. doi: 10.1016/s1521-6934(03)00049-x. PMID: 14614884.
12. Soper JT. Gestational Trophoblastic Disease: Current Evaluation and Management. Obstet Gynecol. 2021 Feb 1;137(2):355-370. doi: 10.1097/AOG.0000000000004240. Erratum in: Obstet Gynecol. 2022 Jan 1;139(1):149. PMID: 33416290; PMCID: PMC7813445.
13. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010 Aug 28;376(9742):717-29. doi: 10.1016/S0140-6736(10)60280-2. Epub 2010 Jul 29. PMID: 20673583.
14. Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, Newlands ES. Choriocarcinoma and partial hydatidiform moles. Lancet. 2000 Jul 1;356(9223):36-9. doi: 10.1016/S0140-6736(00)02432-6. PMID: 10892763.
15. Jauniaux E. Ultrasound diagnosis and follow-up of gestational trophoblastic disease. Ultrasound Obstet Gynecol. 1998 May;11(5):367-77. doi: 10.1046/j.1469-0705.1998.11050367.x. PMID: 9644780.
16. Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG. 2002 Jan;109(1):99-102. doi: 10.1111/j.1471-0528.2002.t01-1-01037.x. PMID: 11843379.
17. Kumar N, Saxena YK, Rathi AK, Chitra R, Kumar P. Host and risk factors for gestational trophoblastic disease: a hospital-based analysis from India. Med Sci Monit. 2003 Oct;9(10):CR442-7. PMID: 14523334.
18. Howat AJ, Beck S, Fox H, Harris SC, Hill AS, Nicholson CM, Williams RA. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol. 1993 Jul;46(7):599-602. doi: 10.1136/jcp.46.7.599. PMID: 8157742; PMCID: PMC501384.
19. Berkowitz RS, Goldstein DP. Current advances in the management of gestational trophoblastic disease. Gynecol Oncol 2013; 128:3.
20. Vassilakos P, Riotton G, Kajii T. Hydatidiform mole: two entities. A morphologic and cytogenetic study with some clinical consideration. Am J Obstet Gynecol 1977; 127:167.
21. Kajii T, Ohama K. Androgenetic origin of hydatidiform mole. Nature 1977; 268:633.
22. Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Engl J Med 2009; 360:1639.
23. Azuma C, Saji F, Tokugawa Y, et al. Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole. Gynecol Oncol 1991; 40:29.
24. Osathanondh R, Berkowitz RS, de Cholnoky C, et al. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease. J Reprod Med 1986; 31:179.
25. Genest DR, Ruiz RE, Weremowicz S, et al. Do nontriploid partial hydatidiform moles exist? A histologic and flow cytometric reevaluation of nontriploid specimens. J Reprod Med 2002; 47:363.
26. Berkowitz RS, Goldstein DP, Bernstein MR. Natural history of partial molar pregnancy. Obstet Gynecol 1985; 66:677.
27. Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994; 39:155.
28. Altieri A, Franceschi S, Ferlay J, et al. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 2003; 4:670.
29. Smith HO. Gestational trophoblastic disease epidemiology and trends. Clin Obstet Gynecol 2003; 46:541.
30. Melamed A, Gockley AA, Joseph NT, et al. Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age. Gynecol Oncol 2016; 143:73.
31. Newlands ES, Paradinas FJ, Fisher RA. Recent advances in gestational trophoblastic disease. Hematol Oncol Clin North Am 1999; 13:225.
32. Maisenbacher MK, Merrion K, Kutteh WH. Single-nucleotide polymorphism microarray detects molar pregnancies in 3% of miscarriages. Fertil Steril 2019; 112:700.
33. Messerli ML, Lilienfeld AM, Parmley T, et al. Risk factors for gestational trophoblastic neoplasia. Am J Obstet Gynecol 1985; 153:294.
34. Sebire NJ, Foskett M, Fisher RA, et al. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG 2002; 109:99.
35. Vargas R, Barroilhet LM, Esselen K, et al. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. J Reprod Med 2014; 59:188.
36. Parazzini F, La Vecchia C, Pampallona S. Parental age and risk of complete and partial hydatidiform mole. Br J Obstet Gynaecol 1986; 93:582.
37. Gockley AA, Melamed A, Joseph NT, et al. The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy. Gynecol Oncol 2016; 140:470.
38. Berkowitz RS, Cramer DW, Bernstein MR, et al. Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol 1985; 152:1016.
39. Parazzini F, La Vecchia C, Mangili G, et al. Dietary factors and risk of trophoblastic disease. Am J Obstet Gynecol 1988; 158:93.
40. Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 1995; 86:775.
41. Mosher R, Goldstein DP, Berkowitz R, et al. Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. J Reprod Med 1998; 43:21.
42. Hou JL, Wan XR, Xiang Y, et al. Changes of clinical features in hydatidiform mole: analysis of 113 cases. J Reprod Med 2008; 53:629.
43. Mangili G, Garavaglia E, Cavoretto P, et al. Clinical presentation of hydatidiform mole in northern Italy: has it changed in the last 20 years? Am J Obstet Gynecol 2008; 198:302.e1.
44. Fine C, Bundy AL, Berkowitz RS, et al. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol 1989; 73:414.
45. Seckin KD, Baser E, Yeral I, et al. The impact of ultrasonographic lesion size and initial human chorionic gonadotropin values on treatment success in cases with complete hydatidiform mole. Eur Rev Med Pharmacol Sci 2013; 17:3381.
46. Amr, E. Togivel: textbook of obstetrics and Gynaecology (5-VOL),2e Specialty, Obs& Gyn, Middle East Libraries, 2023; Page 1842.
47. Mubark NN, Jalil AT, Dilfi SH. Descriptive study of hydatidiform mole according to type and age among patients in Wasit province, Iraq. Global Journal of Public Health Medicine. 2020 Mar 1;2(1):118-24.
48. Ertiro, B. T., Twumasi-Afriyie, S., Blümmel, M., Friesen, D., Negera, D., Worku, M., ... & Kitenge, K. (2013). Genetic variability of maize stover quality and the potential for genetic improvement of fodder value. Field Crops Research, 153, 79-85.
49. Shazly, S. A. E. M., Ali, M. K., Badee, A. Y. A., Alsokkary, A. B. A., Khodary, M. M., & Mostafa, N. A. E. (2012). Twin pregnancy with complete hydatidiform mole and coexisting fetus following ovulation induction with a nonprescribed clomiphene citrate regimen: a case report. Journal of medical case reports, 6(1), 95.
50. Jaffar, R., Kalsoom, R., & Quershi, A. (2011). histopathological review of partial and complete hydati-diform moles in a tertiary care hospital, lahore–pakistan. Biomedica, 27, 76-80.
51. ZH, A. A. A. S., & Almukhtar, K. (2019). Role of the Immunohistochemical Marker (Ki67) in Diagnosis and Classification of Hydatidiform Mole. IIUM Medical Journal Malaysia, 18(3).
52. Savage, P. (2008). Molar pregnancy. The Obstetrician & Gynaecologist, 10(1), 3-8.
53. Steigrad SJ. Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 2003 Dec;17(6):837-847.
54. Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 2003 Nov;4(11):670-678.
55. Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG 2002 Jan;109(1):99-102.
56. Almasi A, Almassinokiani F, Akbari P. Frequency of molar pregnancies in health care centers of Tehran, Iran. Journal of reproduction & infertility. 2014;15(3):157.
57. Parazzini F, Mangili G, La CV, Negri E, Bocciolone L, Fasoli M. Risk factors for gestational trophoblastic disease: a separate analysis of complete and partial hydatidiform moles. Obstetrics and gynecology. 1991;78(6):1039-45.
58. Lorigan, P.C., Sharma, S., Bright, N., Coleman, R. E., & Hancock, B. W. Characteristics of women with recurrent molar pregnancies. Gynecol Oncol, 2000. 78(3 Pt 1): p. 288.
